Full membrane spanning self-assembled monolayers as model systems for UHV-based studies of cell-penetrating peptides
Source abstract
Abstract
Biophysical studies of the interaction of peptides with model membranes provide a simple yet effective approach to understand the transport of peptides and peptide based drug carriers across the cell membrane. Herein, the authors discuss the use of self-assembled monolayers fabricated from the full membrane-spanning thiol (FMST) 3-((14-((4′-((5-methyl-1-phenyl-35-(phytanyl)oxy-6,9,12,15,18,21,24,27,30,33,37-undecaoxa-2,3-dithiahenpentacontan-51-yl)oxy)-[1,1′-biphenyl]-4-yl)oxy)tetradecyl)oxy)-2-(phytanyl)oxy glycerol for ultrahigh vacuum (UHV) based experiments. UHV-based methods such as electron spectroscopy and mass spectrometry can provide important information about how peptides bind and interact with membranes, especially with the hydrophobic core of a lipid bilayer. Near-edge x-ray absorption fine structure spectra and x-ray photoelectron spectroscopy (XPS) data showed that FMST forms UHV-stable and ordered films on gold. XPS and time of flight secondary ion mass spectrometry depth profiles indicated that a proline-rich amphipathic cell-penetrating peptide, known as sweet arrow peptide is located at the outer perimeter of the model membrane.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Lipid Membrane Structure and Behavior · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Max Planck Institute for Polymer Research , Mainz 55128, Germany
University of Washington NESAC/BIO, , Seattle, Washington 98195
Environmental Engineering, Oregon State University School of Chemical, Biological, and , Corvallis, Oregon 97331
References (36)
Show source-provided references
1. Biomacromolecules · 2003 · 4 · 84110.1021/bm0256193 ↗
2. Langmuir · 2008 · 24 · 490110.1021/la800037r ↗
3. Electrochim. Acta · 2008 · 53 · 668010.1016/j.electacta.2008.02.121 ↗
4. Vickerman · 2009 · 4710.1002/9780470721582 ↗
5. J. Vac. Sci. Technol., B · 2011 · 29 · 4D11310.1116/1.3613919 ↗
6. Biomaterials · 2003 · 24 · 363510.1016/S0142-9612(03)00159-5 ↗
7. Horbett · 2013 · 761
8. Langmuir · 2012 · 28 · 210710.1021/la203907t ↗
9. Langmuir · 2010 · 26 · 1643410.1021/la1007389 ↗
10. J. Biomed. Mater. Res. A · 2011 · 97A · 110.1002/jbm.a.33025 ↗
11. J. Vac. Sci. Technol., B · 2010 · 28 · C5D110.1116/1.3456176 ↗
12. Biointerphases · 2013 · 8 · 1810.1186/1559-4106-8-18 ↗
13. 2000
14. J. Am. Chem. Soc. · 2012 · 134 · 875010.1021/ja301711w ↗
15. Trends Mol. Med. · 2012 · 18 · 38510.1016/j.molmed.2012.04.012 ↗
16. Drug Discovery Today · 2012 · 17 · 85010.1016/j.drudis.2012.03.002 ↗
17. J. Biophys. · 2011 · 41472910.1155/2011/414729 ↗
18. Biochim. Biophys. Acta · 2006 · 1758 · 26410.1016/j.bbamem.2006.01.006 ↗
19. Nature · 2003 · 422 · 3710.1038/nature01451 ↗
20. Adv. Drug Delivery Rev. · 2008 · 60 · 47310.1016/j.addr.2007.09.012 ↗
21. Cell Mol. Life Sci. · 2011 · 68 · 231710.1007/s00018-011-0721-7 ↗
22. ChemBioChem · 2011 · 12 · 89610.1002/cbic.201000679 ↗
23. J. Pept. Sci. · 2014 · 20 · 32310.1002/psc.2617 ↗
24. Traffic · 2002 · 3 · 31110.1034/j.1600-0854.2002.30501.x ↗
25. Langmuir · 2010 · 26 · 342310.1021/la902888y ↗
26. Langmuir · 2010 · 26 · 343310.1021/la903267x ↗
27. J Am. Chem. Soc. · 2009 · 131 · 1414810.1021/ja905382m ↗
28. J. Am. Chem. Soc. · 2013 · 135 · 1504010.1021/ja404346p ↗
29. Langmuir · 1998 · 14 · 743510.1021/la9808317 ↗
30. Langmuir · 1999 · 15 · 203710.1021/la981168p ↗
31. J. Chem. Phys. · 1988 · 88 · 407610.1063/1.453862 ↗
32. J. Chem. Phys. · 1998 · 108 · 331310.1063/1.475729 ↗
33. J. Chem. Phys. · 1999 · 111 · 683410.1063/1.479976 ↗
34. Langmuir · 1997 · 13 · 668910.1021/la970205u ↗
35. J. Am. Chem. Soc. · 1998 · 120 · 1206910.1021/ja981872s ↗
36. Prog. Surf. Sci. · 2000 · 65 · 15110.1016/S0079-6816(00)00024-1 ↗